股本结构
单位：万股
| 公告日期 | 2019-04-30 | 2019-05-10 | 2019-03-18 | 2019-03-18 | 2018-09-25 | 2018-08-13 |
|---|---|---|---|---|---|---|
| 证券总股本 | 3353.62 | 3348.40 | 3348.38 | 3348.60 | 3288.41 | 2890.00 |
| 普通股本 | 3353.62 | 3348.40 | 3348.38 | 3348.60 | 3288.41 | 2890.00 |
| 优先股 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 其他 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 变动日期 | 2019-04-24 | 2019-03-31 | 2019-03-01 | 2018-12-31 | 2018-09-25 | 2018-06-30 |
注释：中概股证券总股本=普通股股本/
存托凭证比例
，当前存托凭证比例为：1
历史变动
| 公告日期 | 变动后普通股本（万股） | 变动后优先股（万股） | 变动原因 | 变动日期 |
|---|---|---|---|---|
| 2019-04-30 | 3353.62 | 未披露 | 定期报告 | 2019-04-24 |
| 2019-05-10 | 3348.40 | 未披露 |
更多>>
from December 31, 2018 to March 31, 2019
Forfeiture of restricted share awards
|
2019-03-31 |
| 2019-03-18 | 3348.38 | 未披露 | 定期报告 | 2019-03-01 |
| 2019-03-18 | 3348.60 | 未披露 |
更多>>
from December 31, 2017 to December 31, 2018
Issuance of ordinary shares
Cancellation of restricted share awards
Vesting of restricted share units
|
2018-12-31 |
| 2018-09-25 | 3288.41 | 未披露 | 定期报告 | 2018-09-25 |
| 2018-08-13 | 2890.00 | 未披露 | 定期报告 | 2018-06-30 |
| 2018-04-03 | 2890.47 | 未披露 |
更多>>
from December 31, 2016 to December 31, 2017
Issuance of ordinary shares
Issuance of restricted share awards
|
2017-12-31 |
| 2017-09-28 | 2810.07 | 未披露 |
更多>>
ADSs offered by us 5,360,000 ADSs, each ADS representing one ordinary share
|
2017-09-28 |
| 2017-09-15 | 2274.07 | 未披露 |
更多>>
As of August 31, 2017, assuming the conversion of each separate class of ordinary shares of Nightstar Therapeutics plc into a single class of ordinary shares, which will occur prior to the closing of this offering, an aggregate of 9,410,960 ordinary shares, representing approximately 41.4% of the 22,740,714 ordinary shares that would have been outstanding as of such date, were held by 13 U.S. shareholders of record.
|
2017-08-31 |
| 2017-08-31 | 4579.62 | 未披露 | 定期报告 | 2017-06-30 |
from December 31, 2018 to March 31, 2019
Forfeiture of restricted share awards
from December 31, 2017 to December 31, 2018
Issuance of ordinary shares
Cancellation of restricted share awards
Vesting of restricted share units
from December 31, 2016 to December 31, 2017
Issuance of ordinary shares
Issuance of restricted share awards
ADSs offered by us 5,360,000 ADSs, each ADS representing one ordinary share
As of August 31, 2017, assuming the conversion of each separate class of ordinary shares of Nightstar Therapeutics plc into a single class of ordinary shares, which will occur prior to the closing of this offering, an aggregate of 9,410,960 ordinary shares, representing approximately 41.4% of the 22,740,714 ordinary shares that would have been outstanding as of such date, were held by 13 U.S. shareholders of record.